Abstract
The hemolytic disease of the fetus and newborn (HDFN) is characterized by the presence of maternal antibodies against fetal red cells leading to the premature destruction of these cells. The HDFN is frequently associated with the antibody against antigen D that has high immunogenicity and prevalence in the population. The HDFN still contributes significantly to perinatal morbidity and mor…